Deutsche Bank today maintained a Buy rating on Biogen (NASDAQ: BIIB) with a price target of $240.00. Comments follow Biogen ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View

Deutsche Bank Sees Upside for Biogen's (BIIB) TecfideraApril 29, 2013 12:53 PM Jefferies Lifts Numbers on Biogen (BIIB) Post Q1April 26, 2013 8:03 AM Biogen Idec, Inc. (BIIB) Tops Q1 EPS by 34c; Boosts FY13 OutlookApril 25, 2013 6:31 AM